The Patients' Experience After Stem Cell Transplant
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 60 - 85 |
| Updated: | 5/3/2018 |
| Start Date: | September 1, 2017 |
| End Date: | September 2019 |
| Contact: | Thuy Koll, MD |
| Email: | thuy.koll@unmc.edu |
| Phone: | 402-559-3965 |
Measuring Cognition, Physical Function, and Quality of Life After Hematopoietic Cell Transplantation in Adults >/= 60 Years: A Feasibility Study
In this study, the investigators are looking to understand: 1) how adults ≥ 60 years old
thinking and memory abilities are affected by stem cell transplant; 2) whether these changes
affect day-to-day activities and quality of life; and 3) how thinking and memory abilities
are affected by genetics, depression, anxiety and physical function. Genetics and other
factors may affect the brain's chemicals or structure, and may increase risk for negative
effects on thinking and memory.
thinking and memory abilities are affected by stem cell transplant; 2) whether these changes
affect day-to-day activities and quality of life; and 3) how thinking and memory abilities
are affected by genetics, depression, anxiety and physical function. Genetics and other
factors may affect the brain's chemicals or structure, and may increase risk for negative
effects on thinking and memory.
Participants will undergo neurocognitive testing along with the collection of a saliva sample
and completing a battery of questionnaires and assessments.
and completing a battery of questionnaires and assessments.
Inclusion Criteria:
1. Between the ages of 60-85
2. Diagnosed with a hematological malignancy
3. Is considering an autologous or allogeneic stem cell transplant OR has undergone stem
cell transplant in the past 12 months and seen by the PI for pre-transplant
evaluation.
4. Is able to read, write, speak, and understand English
Exclusion Criteria:
1. As per self report or medical record, history of central nervous system involvement
and/or history of cranial irradiation or intrathecal chemotherapy except for patients
with history of prophylactic intrathecal chemotherapy.
2. As per self report or medical record, history of stroke, head injury, neurosurgery,
seizure disorder, or demyelinating disorder.
3. As per self report or medical record, history of substance use disorder.
4. As per self report or in the judgement of the consenting professional, uncorrected
vision loss.
5. As per self report or medical record, primary psychiatric disorder necessitating
inpatient treatment in the last 12 months.
We found this trial at
1
site
Emile St
Omaha, Nebraska 68198
Omaha, Nebraska 68198
(402) 559-4000
Principal Investigator: Thuy Koll, MD
Phone: 402-559-3965
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
Click here to add this to my saved trials
